CCL7 and metabolic syndrome: We predict that Fic regulation of the UPR will play a role in mitigating the deleterious effects of UPR activation in a variety of tissues with UPR-associated diseases, including retinal degeneration, atherosclerosis, metabolic syndrome, and various neurodegenerative disorders.